Nováková L, Matysová L, Havlíková L, Solich P
Department of Analytical Chemistry, Faculty of Pharmacy, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic.
J Pharm Biomed Anal. 2005 Apr 29;37(5):899-905. doi: 10.1016/j.jpba.2004.09.012.
Indomethacin forms by decomposition two degradation products: 4-chlorobenzoic acid and 5-methoxy-2-methylindoleacetic acid. They have to be monitored together with an active substance both during manufacturing process and storage of pharmaceuticals. European Pharmacopoeia (Ph. Eur. 4) describes titration method for determination of indomethacin, which is not very convenient in this case for practical use. Therefore, high performance liquid chromatography is the method-of-choice enabling determination of active substance and its degradation products during one-step procedure simultaneously and automatically. We have developed a fast, simple and fully automated analytical method for determination of indomethacin and its two impurities in pharmaceutical preparation using HPLC with UV detection. Various stationary phases were tested, especially new types of Zorbax columns made by Agilent. While the conventional C18 stationary phases were not convenient enough to achieve quick and reliable separation, Zorbax-Phenyl analytical column (75 mm x 4.6 mm, 3.5 microm) enables separation of indomethacin and its two degradation products during 7.5 min. Chromatography was performed using isocratic elution with binary mobile phase composed of acetonitrile and 0.2% phosphoric acid (50:50, v/v) at flow rate 0.6 ml/min. Even faster separation of standards was obtained with analytical column Zorbax SB-CN (150 mm x 4.6 mm, 5 microm). The separation was effected with mobile phase of the same composition, only the flow rate was increased to 1.2 ml/min. The analytical run was shortened to 5 min. Both methods use detection wavelength 237 nm and both can use either ketoprofen or flurbiprofen as internal standard for quantitation. The first method was finally chosen for validation because of the occurrence of placebo interferences in the case of using Zorbax SB-CN. System suitability parameters and validation parameters including method precision, accuracy, linearity, selectivity and robustness were set up. Afterwards, the method was successfully applied for the practical determination of indomethacin and its degradation products in a topical gel and for compound degradation control during stability studies.
4-氯苯甲酸和5-甲氧基-2-甲基吲哚乙酸。在药品的生产过程和储存期间,它们必须与活性物质一起进行监测。欧洲药典(《欧洲药典》第4版)描述了测定吲哚美辛的滴定法,但在这种情况下实际使用起来不太方便。因此,高效液相色谱法是首选方法,它能够在一步程序中同时自动测定活性物质及其降解产物。我们开发了一种快速、简单且全自动的分析方法,使用带紫外检测的高效液相色谱法测定药物制剂中的吲哚美辛及其两种杂质。测试了各种固定相,特别是安捷伦公司生产的新型Zorbax柱。虽然传统的C18固定相不足以实现快速可靠的分离,但Zorbax-苯基分析柱(75 mm×4.6 mm,3.5微米)能够在7.5分钟内分离吲哚美辛及其两种降解产物。色谱分析采用等度洗脱,二元流动相由乙腈和0.2%磷酸(50:50,v/v)组成,流速为0.6 ml/min。使用Zorbax SB-CN分析柱(150 mm×4.6 mm,5微米)能更快地分离标准品。分离采用相同组成的流动相,只是流速提高到1.2 ml/min。分析运行时间缩短至5分钟。两种方法均使用237 nm检测波长,且均可使用酮洛芬或氟比洛芬作为定量内标。由于使用Zorbax SB-CN时出现安慰剂干扰,最终选择了第一种方法进行验证。建立了系统适用性参数和验证参数,包括方法精密度、准确度、线性、选择性和稳健性。之后,该方法成功应用于实际测定局部用凝胶中的吲哚美辛及其降解产物,并用于稳定性研究期间的化合物降解控制。